| Ytd | 516.92% | |
| 1y | 206.62% |
| Open | 3.91 | Prev Close | 3.83 | Low | 3.82 | High | 4.63 | Mkt Cap | 4.95M |
| Vol | 301.15K | Avg Vol | 64.22K | EPS | -14.29 | P/E | N/A | Forward P/E | -2.94 |
| Beta | 0.80 | Short Ratio | 0.27 | Inst. Own | 0.48% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 09-01 | 50-d Avg | 4.26 | 200-d Avg | 5.06 | 1yr Est | 12.00 |
GLMD News
Standby Equity Purchase Agreement (SEPA) with YA II PN, LTD. (Yorkville) will be terminated effectiv
Gainers Aardvark Therapeutics (NASDAQ:AARD) shares increased by 8.5% to $6.28 during Friday's a
Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD - Get Free Report) shares crossed above its 50 day moving
The prospective, single-arm study enrolled 32 colorectal cancer patients at three leading clinical c
Xtandi® (enzalutamide) is indicated as monotherapy for the treatment of patients with non-metastatic
Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD - Get Free Report) shares passed below its 200-day moving
Gainers Universe Pharmaceuticals (NASDAQ:UPC) stock increased by 121.2% to $6.99 during Monday'
Aramchol meglumine is the only SCD1 inhibitor with an established clinical safety profile and confir
Galmed Pharmaceuticals (NASDAQ: GLMD - Get Free Report) is expected to issue its results before the
Crown Holdings Inc (CCK) stock gained 16.4% in pre-market trading after reporting strong Q2 results
Gainers Shuttle Pharmaceuticals (NASDAQ:SHPH) shares moved upwards by 25.1% to $3.79 during Monday&
Galmed has developed, in collaboration with Barcode Nanotech, a unique proprietary lipid nanoparticl
Gainers Q32 Bio (NASDAQ:QTTB) stock moved upwards by 44.4% to $16.19 during Friday's after-mark
Gainers Liminatus Pharma (NASDAQ:LIMN) stock increased by 40.9% to $0.16 during Thursday's pre-
Gainers Curis (NASDAQ:CRIS) stock rose 9.0% to $0.46 during Wednesday's after-market session. T
Gainers Quoin Pharmaceuticals (NASDAQ:QNRX) shares rose 40.3% to $4.56 during Tuesday's after-m
Colospan Ltd. ("Colospan") provides Galmed Pharmaceuticals Ltd.
Transaction will add FDA Breakthrough Device-Designated technology with active U.S. pivotal IDE tria
https://www.gov.uk/government/news/resmetirom-rezdiffra-authorised-to-treat-metabolic-dysfunction-as
- Tissue Dynamics identified a previously unrecognized metabolic mechanism driving cardiac fibrosis
Results from Study AM-001 mark a pivotal advance through the transition to a once daily lower 400mg
Novel vascularized, sensor-embedded cardiac organoid model will focus on chronic post-MI remodeling
Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD - Get Free Report) was the target of a large growth in sho
Recently, Galmed announced breakthrough medicinal chemistry work converting Aramchol into a brain-pe
Clearsign Technologies Corp (NASDAQ: CLIR) shares rose 11.3% in pre-market trading after reporting b
Galmed said it developed a new formulation of its SCD1 inhibitor, Aramchol, designed to cross the bl
98% of drugs do not reach the brain, as the blood–brain barrier (BBB) separates peripheral blood cir
TEL AVIV, Israel, March 31, 2026 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed
Surrozen (NASDAQ: SRZN - Get Free Report) and Galmed Pharmaceuticals (NASDAQ: GLMD - Get Free Report
Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD - Get Free Report) was the recipient of a large decrease i
Shares of Agenus Inc. (NASDAQ: AGEN) fell sharply during Monday’s session. Agenus disclosed a 1-for
Shares of Esperion Therapeutics, Inc. (NASDAQ: ESPR) shares rose sharply during today’s pre-market
On Tuesday, 647 companies set new 52-week lows.
On Monday, 369 companies set new 52-week lows.
On Tuesday, 386 stocks made new 52-week lows.